clinical trial · NCT07409285
The EMBRACE Registry: European Post-Market Registry for Catheter Based Mitral Valve Replacement
HighLife SAS·—·not yet recruiting·n = 150
Mitral Regurgitation
brief summary
Post-market registry for post-market surveillance, as part of the post-market plan, for the HighLife transcatheter, transseptal, mitral valve replacement system in a real world commercial setting.
started
Mar 14, 2026
primary completion
Apr 15, 2029
completion
Apr 15, 2031
last updated
Feb 13, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol